Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim A. Wuyts, Susanne Stowasser, Manuel Quaresma, Rainer Georg Goeldner, Rozsa Schlenker-Herceg, Martin Kolb, S. Abe, M. Aburto, O. Acosta, C. Andrews, D. Antin-Ozerkis, G. ArceM. Arias, S. Avdeev, A. Barczyk, R. Bascom, E. Bazdyrev, P. Beirne, E. Belloli, M. A. Bergna, E. Bergot, N. Bhatt, S. Blaas, B. Bondue, F. Bonella, E. Britt, K. Buch, J. Burk, H. Cai, A. Cantin, D. M. Castillo Villegas, A. Cazaux, S. Cerri, S. Chaaban, N. Chaudhuri, V. Cottin, B. Crestani, G. Criner, C. Dahlqvist, S. Danoff, J. Dematte D'Amico, D. Dilling, P. Elias, N. Ettinger, J. Falk, E. R. Fernández Pérez, A. Gamez-Dubuis, G. Giessel, A. Gifford, M. Glassberg, C. Glazer, J. Golden, L. Gómez Carrera, J. Guiot, R. Hallowell, H. Hayashi, J. Hetzel, N. Hirani, L. Homik, B. Hope-Gill, D. Hotchkin, K. Ichikado, M. Ilkovich, Y. Inoue, S. Izumi, E. Jassem, L. Jones, S. Jouneau, R. Kaner, J. Kang, T. Kawamura, R. Kessler, Y. Kim, K. Kishi, H. Kitamura, M. Kolb, Y. Kondoh, C. Kono, D. Koschel, M. Kreuter, T. Kulkarni, J. Kus, F. Lebargy, A. León Jiménez, Q. Luo, Y. Mageto, T. M. Maher, S. Makino, S. Marchand-Adam, C. Marquette, R. Martinez, M. Martínez, R. Maturana Rozas, Y. Miyazaki, S. Moiseev, M. Molina-Molina, L. Morrison, L. Morrow, T. Moua, A. Nambiar, Y. Nishioka, H. Nunes, M. Okamoto, J. Oldham, M. Otaola, M. Padilla, J. S. Park, N. Patel, A. Pesci, W. Piotrowski, L. Pitts, H. Poonyagariyagorn, A. Prasse, S. Quadrelli, W. Randerath, R. Refini, M. Reynaud-Gaubert, F. Riviere, J. A. Rodríguez Portal, I. Rosas, M. Rossman, Z. Safdar, T. Saito, N. Sakamoto, M. Salinas Fénero, J. Sauleda, S. Schmidt, M. B. Scholand, M. Schwartz, S. Shapera, O. Shlobin, B. Sigal, A. Silva Orellana, D. Skowasch, J. W. Song, S. Stieglitz, H. Stone, M. Strek, T. Suda, H. Sugiura, H. Takahashi, H. Takaya, T. Takeuchi, K. Thavarajah, L. Tolle, S. Tomassetti, K. Tomii, C. Valenzuela, C. Vancheri, F. Varone, S. Veeraraghavan, A. Villar, S. Weigt, L. Wemeau, W. Wuyts, Z. Xu, V. Yakusevich, Y. Yamada, H. Yamauchi, D. Ziora

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial'. Together they form a unique fingerprint.

Medicine & Life Sciences